Risankizumab for the treatment of moderate-to-severe psoriasis: Real-world data from the Czech Republic BIOREP Registry

被引：0
|
作者：
Kojanova, Martina [1 ,2 ]
Fialova, Jorga [1 ,2 ]
Cetkovska, Petra [3 ]
Gkalpakiotis, Spyridon [4 ,5 ]
Machovcova, Alena [6 ]
Arenberger, Petr [4 ,5 ]
Stork, Jiri [2 ,7 ]
Dolezal, Tomas [8 ]
Strosova, Daniela [8 ]
机构：
[1] Charles Univ Prague, Dept Dermatovenereol, Fac Med 1, Prague, Czech Republic
[2] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med Pilsen, Dept Dermatovenereol, Prague, Czech Republic
[4] Charles Univ Prague, Fac Med 3, Dept Dermatovenereol, Prague, Czech Republic
[5] Kralovske Vinohrady Univ Hosp, Prague, Czech Republic
[6] Motol Univ Hosp, Prague, Czech Republic
[7] Charles Univ Prague, Dept Dermatovenereol, Fac Med 1, Prague, Czech Republic
[8] Value Outcomes, Prague, Czech Republic
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43067
引用
收藏
页码：AB83 / AB83
页数：1
相关论文
共 50 条
  • [1] Real-World Data on Brodalumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: An Observational Study from the Czech Republic BIOREP Registry
    Kojanova, Martina
    Turkova, Barbora
    Gkalpakiotis, Spyridon
    Cetkovska, Petra
    Fialova, Jorga
    Dolezal, Tomas
    Machovcova, Alena
    Apol, Eydna Didriksen
    ADVANCES IN THERAPY, 2024, 41 (10) : 3951 - 3971
  • [2] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [3] Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry
    Kojanova, Martina
    Tanczosova, Milena
    Strosova, Daniela
    Cetkovska, Petra
    Fialova, Jorga
    Dolezal, Tomas
    Machovcova, Alena
    Gkalpakiotis, Spyridon
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2578 - 2586
  • [4] Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic
    Gkalpakiotis, Spyridon
    Cetkovska, Petra
    Arenberger, Petr
    Dolezal, Tomas
    Arenbergerova, Monika
    Velackova, Barbora
    Fialova, Jorga
    Kojanova, Martina
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1345 - 1355
  • [5] Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic
    Spyridon Gkalpakiotis
    Petra Cetkovska
    Petr Arenberger
    Tomas Dolezal
    Monika Arenbergerova
    Barbora Velackova
    Jorga Fialova
    Martina Kojanova
    Dermatology and Therapy, 2021, 11 : 1345 - 1355
  • [6] Evaluating risankizumab for moderate-to-severe plaque psoriasis: real-world outcomes from an international study
    Bagit, Ahmed
    Maliyar, Khalad
    Mansour, Mark
    Georgakopoulos, Jorge
    Rankin, Brian
    Lytvyn, Yuliya
    Zaaroura, Hiba
    Park, Ye-Jean
    Wang, Emilie
    Mufti, Asfandyar
    Torres, Tiago
    Le, Ana Maria
    Vender, Ronald
    Prajapati, Vimal H.
    Yeung, Jensen
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [7] Real-world patient-reported outcomes with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura K.
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [8] Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic
    Kojanova, Martina
    Cetkovska, Petra
    Strosova, Daniela
    Fialova, Jorga
    Arenberger, Petr
    Dolezal, Tomas
    Gkalpakiotis, Spyridon
    DERMATOLOGY AND THERAPY, 2021, 11 (02) : 543 - 553
  • [9] Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic
    Martina Kojanova
    Petra Cetkovska
    Daniela Strosova
    Jorga Fialova
    Petr Arenberger
    Tomas Dolezal
    Spyridon Gkalpakiotis
    Dermatology and Therapy, 2021, 11 : 543 - 553
  • [10] Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry
    Jan Hugo
    Martina Kojanova
    Barbora Turkova
    Spyridon Gkalpakiotis
    Dermatology and Therapy, 2023, 13 : 787 - 801
12345